KYMR - Kymera Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYMR is currently covered by 22 analysts with an average price target of $129.44. This is a potential downside of $2.29 (-1.74%) from yesterday's end of day stock price of $131.73.

Kymera Therapeutics's activity chart (see below) currently has 214 price targets and 208 ratings on display. The stock rating distribution of KYMR is 94.23% BUY and 5.77% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 90.49% with an average time for these price targets to be met of 292.94 days.

Highest price target for KYMR is $170, Lowest price target is $97, average price target is $129.44.

Most recent stock forecast was given by BRIAN ABRAHAMS from RBC on 02-Nov-2026. First documented stock forecast 15-Sep-2020.

Best performing analysts who are covering KYMR - Kymera Therapeutics:

Leah Rush Cann Eliana Merle Judah Frommer Andrew Fein Etzer Darout Edward Tenthoff

Currently out of the existing stock ratings of KYMR, 49 are a BUY (94.23%), 3 are a HOLD (5.77%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 02-Nov-2026

$116

$-15.73 (-11.94%)

$112

6 days ago
(02-Nov-2026)

4/6 (66.67%)

$-10.63 (-8.39%)

100

Buy Since 30-Jun-2023

$150

$18.27 (13.87%)

$136

6 days ago
(02-Nov-2026)

14/15 (93.33%)

$23.37 (18.46%)

179

Buy Since 20-May-2021

$170

$38.27 (29.05%)

$139

6 days ago
(02-Nov-2026)

5/7 (71.43%)

$43.37 (34.25%)

549

Buy Since 27-Oct-2026

$146

$14.27 (10.83%)

$79

12 days ago
(27-Oct-2026)

2/3 (66.67%)

$31.16 (27.13%)

97

Buy Since 27-Jun-2025

$150

$18.27 (13.87%)

$120

1 months 3 days ago
(05-Oct-2026)

8/9 (88.89%)

$40.15 (36.55%)

116

Show more analysts

Please expand the browser size to see the chart

What is KYMR (Kymera Therapeutics) average time for price targets to be met?

On average it took 293 days for the stock forecasts to be reached, with an average price target met ratio of 90.49%.

Which analyst most recently updated their price target on KYMR (Kymera Therapeutics)?

Brian Abrahams

Which analyst has the most public recommendations on KYMR (Kymera Therapeutics)?

Brian Abrahams works at RBC and has 42 price targets and 25 ratings on KYMR

Which analyst is the currently most bullish on KYMR (Kymera Therapeutics)?

Eliana Merle with the highest potential upside of $38.27

Which analyst is the currently most reserved on KYMR (Kymera Therapeutics)?

Richard Law with the lowest potential downside of -$94.73
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?